secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2024-07-25T23:59:59+00:00
Accession:  0000313143-24-000044
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

All nine Haemonetics directors elected; say-on-pay and auditor ratification pass
--------------------------------------------------------------------------------

- Quorum of 95.99% (48.9M of 50.95M shares) represented at the July 25, 2024 annual meeting.
- Each director nominee received >46.7M for votes; Christopher A. Simon led with 47.6M.
- Advisory vote on executive compensation passed with 46.2M for, 1.5M against, 0.1M abstain.
- Ratification of Ernst & Young LLP as independent auditor approved with 47.7M for, 1.0M against, 0.1M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314324000044/0000313143-24-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314324000044/hae-20240725.htm
  HTML page:      https://secwatch.observer/filing/0000313143-24-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer